← Eichor
Condition: Severe Eosinophilic Asthma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Severe Eosinophilic Asthma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Predictive Signature of Benralizumab Response
Phase 4 · 20 location(s) · Nantes University Hospital · NCT04565483A Non-interventional, Prospective Study With Benralizumab
Phase N/A · 41 location(s) · AstraZeneca · NCT06422078A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · 58 location(s) · Kymera Therapeutics, Inc. · NCT07323654Real Life Study of Biologicals in Patients With Severe CRSwNP
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05938972A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
Phase N/A · 28 location(s) · AstraZeneca · NCT07214753This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patient
Phase N/A · 36 location(s) · AstraZeneca · NCT06862206Efficacy and Safety Study of 610 in Patients With Severe Asthma
Phase 3 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT06323213
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.